These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21654659)

  • 1. Spat over IMI funding and intellectual property.
    Sinha G
    Nat Biotechnol; 2011 Jun; 29(6):473. PubMed ID: 21654659
    [No Abstract]   [Full Text] [Related]  

  • 2. IMI moves forward.
    Strohmeier R; Draghia-Akli R; Rys A; Silvan PO; Lennon T; Incerti C; Bergström R; Chibout S; Doliveux R; Andersen PH
    Nat Biotechnol; 2011 Aug; 29(8):689-90; reply 690. PubMed ID: 21822236
    [No Abstract]   [Full Text] [Related]  

  • 3. Mayo clinic office of intellectual property-exploring and encouraging invention and innovation through unique mayo clinic funding opportunities.
    Anderson K
    J Cardiovasc Transl Res; 2008 Dec; 1(4):278-80. PubMed ID: 20559935
    [No Abstract]   [Full Text] [Related]  

  • 4. In vogue with venture.
    Patou G
    Nat Biotechnol; 2011 Nov; 29(11):967-9. PubMed ID: 22175076
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicine. Can intellectual property save drug development?
    FitzGerald GA
    Science; 2012 Oct; 338(6106):483-4. PubMed ID: 23112323
    [No Abstract]   [Full Text] [Related]  

  • 6. [From drug cost to drug price: steps and decisional processes].
    Bruyninckx M; Nourissier C
    Presse Med; 2012 May; 41 Suppl 1():S40-3. PubMed ID: 22487715
    [No Abstract]   [Full Text] [Related]  

  • 7. Intellectual property. Device trade.
    Mathieson S
    Health Serv J; 2004 Jan; 114(5889):28-9. PubMed ID: 14733075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Members need only apply.
    Nat Biotechnol; 2011 Jul; 29(7):551. PubMed ID: 21747362
    [No Abstract]   [Full Text] [Related]  

  • 9. Shaping the future of safer innovative drugs in Europe.
    Mestres J; Bryant SD; Zamora I; Gasteiger J
    Nat Biotechnol; 2011 Sep; 29(9):789-90. PubMed ID: 21904315
    [No Abstract]   [Full Text] [Related]  

  • 10. Can open-source drug R&D repower pharmaceutical innovation?
    Munos B
    Clin Pharmacol Ther; 2010 May; 87(5):534-6. PubMed ID: 20407458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Description of the French players from Avenir's investment program: the role of MabDesign].
    Groux N; Pontremoli R; Vuddamalay G; Richard G; Pons D
    Med Sci (Paris); 2019 Dec; 35(12):1198-1201. PubMed ID: 31903939
    [No Abstract]   [Full Text] [Related]  

  • 12. Amid fears of idea theft, NIH targets foreign funding links.
    Kaiser J; Malakoff D
    Science; 2018 Aug; 361(6405):834. PubMed ID: 30166468
    [No Abstract]   [Full Text] [Related]  

  • 13. Funding breakthrough therapies: A systematic review and recommendation.
    Hanna E; Toumi M; Dussart C; Borissov B; Dabbous O; Badora K; Auquier P
    Health Policy; 2018 Mar; 122(3):217-229. PubMed ID: 29223847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US drug manufacturers set up joint testing group.
    Davies E
    BMJ; 2012 Sep; 345():e6394. PubMed ID: 23002149
    [No Abstract]   [Full Text] [Related]  

  • 15. Too big to succeed?
    Petsko GA
    Genome Biol; 2009; 10(3):103. PubMed ID: 19344496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. China spurs pharma innovation.
    Hughes B
    Nat Rev Drug Discov; 2010 Aug; 9(8):581-2. PubMed ID: 20671751
    [No Abstract]   [Full Text] [Related]  

  • 17. Universities shun Europe's drug initiative.
    Gilbert N
    Nature; 2010 Jul; 466(7304):306-7. PubMed ID: 20631770
    [No Abstract]   [Full Text] [Related]  

  • 18. Pay drug companies $1bn for each new antibiotic, says report.
    Owen J
    BMJ; 2016 May; 353():i2863. PubMed ID: 27198868
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical education companies got $170m in grants from 14 drug firms in 2010, study finds.
    Kmietowicz Z
    BMJ; 2013 Dec; 347():f7534. PubMed ID: 24353103
    [No Abstract]   [Full Text] [Related]  

  • 20. Open-minded to open innovation and precompetitive collaboration.
    Wagner JA
    Clin Pharmacol Ther; 2010 May; 87(5):511-5. PubMed ID: 20407451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.